[Federal Register Volume 77, Number 175 (Monday, September 10, 2012)]
[Notices]
[Pages 55477-55478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-22027]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research And Quality


Special Emphasis Panel Meeting

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice of SEP meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10 (a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for 
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP) 
meeting on ``Partnerships for Sustainable Research and Dissemination of 
Evidence-Based Medicine (R24)''.

DATES: September 20-21, 2012 (Open on September 20 from 8:00 a.m. to 
8:15 a.m. and closed for the remainder of the meeting).
    This notice is being published less than 15 days prior to the 
September 20-21 meeting, due to the time constraints of reviews and 
funding cycles.

ADDRESSES: Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD 
20814.

FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of 
members, agenda or minutes of the non-confidential portions of this 
meeting

[[Page 55478]]

should contact: Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone 
(301) 427-1554.
    Agenda items for this meeting are subject to change as priorities 
dictate.

SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of 
experts in fields related to health care research who are invited by 
the Agency for Healthcare Research and Quality (AHRQ), and agree to be 
available, to conduct on an as needed basis, scientific reviews of 
applications for AHRQ support. Individual members of the Panel do not 
attend regularly-scheduled meetings and do not serve for fixed terms or 
a long period of time. Rather, they are asked to participate in 
particular review meetings which require their type of expertise.
    Substantial segments of the SEP meeting referenced above will be 
closed to the public in accordance with the provisions set forth in 5 
U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 
552b(c)(6). Grant applications for ``Partnerships for Sustainable 
Research and Dissemination of Evidence-Based Medicine (R24)'' are to be 
reviewed and discussed at this meeting. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Dated: August 30, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-22027 Filed 9-7-12; 8:45 am]
BILLING CODE 4160-90-M